Cargando…
Poor responders in in vitro fertilization (IVF) therapy: the challenge continues
Poor responders represent more than a third of women undergoing assisted reproduction. Typically they are patients with advanced maternal age and low ovarian reserve. However, there is a younger group that unexpectedly demonstrates impaired response to controlled ovarian hyperstimulation. The etiolo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universa Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987493/ https://www.ncbi.nlm.nih.gov/pubmed/24753855 |
_version_ | 1782479690375626752 |
---|---|
author | Oehninger, S. |
author_facet | Oehninger, S. |
author_sort | Oehninger, S. |
collection | PubMed |
description | Poor responders represent more than a third of women undergoing assisted reproduction. Typically they are patients with advanced maternal age and low ovarian reserve. However, there is a younger group that unexpectedly demonstrates impaired response to controlled ovarian hyperstimulation. The etiologies in many of these cases are still unclear. In our program, the determination of basal cycle day 3 serum FSH, LH and E(2) levels, measurement of AMH, and the estimation of the basal antral follicular count by transvaginal ultrasonography, are the preferred screening tests for ovarian reserve in all IVF patients, and together with the woman’s age, determine the ovarian stimulation regimen to be chosen for the cycle treatment. In spite of a variety of protocols and adjuvant therapies of unproven benefit, these patients have compromised outcomes and continue to represent a challenge to reproductive endocrinologists. |
format | Online Article Text |
id | pubmed-3987493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Universa Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-39874932014-04-21 Poor responders in in vitro fertilization (IVF) therapy: the challenge continues Oehninger, S. Facts Views Vis Obgyn Viewpoint Poor responders represent more than a third of women undergoing assisted reproduction. Typically they are patients with advanced maternal age and low ovarian reserve. However, there is a younger group that unexpectedly demonstrates impaired response to controlled ovarian hyperstimulation. The etiologies in many of these cases are still unclear. In our program, the determination of basal cycle day 3 serum FSH, LH and E(2) levels, measurement of AMH, and the estimation of the basal antral follicular count by transvaginal ultrasonography, are the preferred screening tests for ovarian reserve in all IVF patients, and together with the woman’s age, determine the ovarian stimulation regimen to be chosen for the cycle treatment. In spite of a variety of protocols and adjuvant therapies of unproven benefit, these patients have compromised outcomes and continue to represent a challenge to reproductive endocrinologists. Universa Press 2011 /pmc/articles/PMC3987493/ /pubmed/24753855 Text en Copyright: © 2011 Facts, Views & Vision http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Viewpoint Oehninger, S. Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title | Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title_full | Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title_fullStr | Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title_full_unstemmed | Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title_short | Poor responders in in vitro fertilization (IVF) therapy: the challenge continues |
title_sort | poor responders in in vitro fertilization (ivf) therapy: the challenge continues |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987493/ https://www.ncbi.nlm.nih.gov/pubmed/24753855 |
work_keys_str_mv | AT oehningers poorrespondersininvitrofertilizationivftherapythechallengecontinues |